Supplier News

The addition of 20,000 sq. ft. of manufacturing and office space increases Avecia’s Milford, Ma, oligonucleotide capacity to 3.0 mol.

Higher-flow peristaltic pumps from Watson-Marlow Fluid Technology Group are designed for upstream and downstream bioprocessing with single-use fluid path assemblies.

GE Healthcare’s Dharmacon business and CordenPharma contract manufacturing enter a strategic collaboration to accelerate the oligonucleotide development process.

A $5.5 billion acquisition brings Capsugel’s oral dosage delivery capabilities to Lonza’s portfolio.

Samsung BioLogics signs $55.5 million agreement to manufacture tildrakizumab for Sun Pharma.

Patheon will add spray drying, sterile manufacturing, and packaging capabilities to four facilities.

Quattroflow’s EZ-Set Pump Chamber Replacing System for its single-use pumps allows users to change chambers quickly by hand.

Sartorius Stedim Biotech expanded its range of single-use membrane chromatography solutions with Sartobind Cassettes.

The company announced that it has completed its 100th program using the pAVEway protein expression system, which was originally introduced to the market in 2007.

The RT-PCR kit can simultaneously screen samples for Zika, dengue, and chikungunya arbovirus RNAs.

The company announced its new ISQ EC Single Quadrupole mass spectrometer and the new range of Thermo Scientific MAbPac RP 1-mm columns.

The company was granted patent rights to the use of CRISPR in a genomic integration method for eukaryotic cells.

The company added new products to its InfinityLab LC Series which will be showcased at HPLC 2017 in Prague.

Selexis will be integrated with KBI Biopharma, which was acquired by JSR Life Sciences in 2015.

The companies announced an agreement where Dorizoe will work with Baxter to develop more than 20 generic injectable products.

Sartorius Stedim Biotech combined the company’s ambr 15 bioreactor system with the Nova BioProfile FLEX2 cell culture analyzer for laboratory experiments.

The company added a 40,000-ft2 purpose-built R&D center at 17112 Armstrong Ave, Irvine, CA.

The companies are partnering to provide new fill/finish facilities and solutions for biopharmaceutical products.

The companies are collaborating to interface the Waters Acquity QDa Mass Detector with the IonSense DART ionization source.

The new training center will feature technologies that boost biomanufacturing.

The company will be acquired for $21.75 per share in cash.

The new UPS facility in Columbia will serve the growing pharmaceutical, biopharma, and medical device industry in Latin America.

Phenomenex opened a new manufacturing and development facility in CA for the company’s gas chromatography columns.

The companies expanded their collaboration to evaluate Opdivo and Adcetris in a Phase III trial as a treatment for relapsed/refractory or transplant-ineligible advanced classical Hodgkin lymphoma.

Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.

BioVectra will open its new microbial fermentation and complex chemistry site, including the capability to handle high-potency APIs, by the end of 2017.

The company installed the FlexFactory to support its biosimilar production.

The company developed proxy-CRISPR which provides access to previously unreachable areas of the genome.